Liste des publications GINECO - Cancer Ovaire 2011
- Calypso – Article (Annals of Oncology)
L. Gladieff
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial
Gynecologic Oncology - Octobre 2011 (réf. PubMed : PMID: 21976386 [PubMed - in process]) - Calypso – Article (British Journal of Cancer)
C. K. Lee
Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.
British Journal of Cancer - Juillet 2011 (réf. PubMed : PMID: 21750553 [PubMed - indexed for MEDLINE] - PMCID: PMC3172911 [Available on 2012/7/26]) - Calypso – Article (Journal of the National Cancer Institute)
C. K. Lee
Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer
Annals of Oncology - 11 Août 2011 (réf. PubMed : PMID: 21840849 [PubMed - indexed for MEDLINE]) - Calypso – Article (British Journal of Cancer)
C. K. Lee
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer.
British Journal of Cancer - Octobre 2011 (réf. PubMed : PMID: 21915127 [PubMed - indexed for MEDLINE] - PMCID: PMC3208495 [Available on 2012/10/11]) - Calypso – Article (Gynecologic Oncology)
F. Joly
Decreased hypersensitivity reactions with carboplatin pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial
Gynecologic Oncology - Août 2011 (réf. PubMed : PMID: 21575983 [PubMed - indexed for MEDLINE]) - Calypso – Article (Annals of Oncology)
J. E. Kurtz
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study
Annals of Oncology - 14 Mars 2011 (réf. PubMed : PMID: 21402619 [PubMed - indexed for MEDLINE]) - Cartaxhy – Article (Annals of Oncology)
A. Lortholary
Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO)
Annals of Oncology - 11 Mai 2011 (réf. PubMed : PMID: 21562072 [PubMed - as supplied by publisher])
Haut de page
Modifié le
30-08-2016 16:16:19